Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
Shirin Ardeshir‐Rouhani‐Fard, Sophie D. Fosså, Robert Huddart, et al.
Ear and Hearing (2022) Vol. 43, Iss. 3, pp. 794-807
Open Access | Times Cited: 20

Showing 20 citing articles:

Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy
Victoria A. Sanchez, Megan M. Shuey, Paul C. Dinh, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 12, pp. 2211-2226
Open Access | Times Cited: 24
Comparing Hearing Aid Outcomes in Adults Using Over-the-Counter and Hearing Care Professional Service Delivery Models
De Wet Swanepoel, Ilze Oosthuizen, Marien Alet Graham, et al.
American Journal of Audiology (2023) Vol. 32, Iss. 2, pp. 314-322
Open Access | Times Cited: 23
Impact of Cisplatin on Hearing: Analysis Using PTA, High‐Frequency Audiometry, DPOAE, and Speech‐in‐Noise Test
Juhi Irfana Basheer, Balakrishnan Ramaswamy, Poorvi V. Sharma, et al.
OTO Open (2025) Vol. 9, Iss. 1
Open Access
Activated mTORC1 signaling pathway aggravates cisplatin induced oxidative damage by inhibiting autophagy in mouse cochlear hair cells
Nana Xu, Yin-Chuan Wen, Jing Pan, et al.
Neuropharmacology (2025), pp. 110433-110433
Closed Access
Prevention and treatment of cisplatin‐induced ototoxicity in adults: A systematic review
Juan Esteban Correa‐Morales, Sara Giraldo‐Moreno, Nidia Mantilla‐Manosalva, et al.
Clinical Otolaryngology (2023) Vol. 49, Iss. 1, pp. 1-15
Open Access | Times Cited: 8
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
Victoria A. Sanchez, Paul C. Dinh, Jennessa Rooker, et al.
Journal of Cancer Survivorship (2023) Vol. 17, Iss. 1, pp. 27-39
Open Access | Times Cited: 7
Audiologists’ perceived value of ototoxicity management and barriers to implementation for at-risk cancer patients in VA: the OtoMIC survey
Dawn Konrad‐Martin, Rachel S Polaski, J. Riley DeBacker, et al.
Journal of Cancer Survivorship (2023) Vol. 17, Iss. 1, pp. 69-81
Open Access | Times Cited: 6
Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus
Steven W. Cheung, Jennifer Henderson‐Sabes, Judith Mastick, et al.
BMJ Supportive & Palliative Care (2022) Vol. 13, Iss. 3, pp. 345-353
Closed Access | Times Cited: 9
Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review
J. Riley DeBacker, Garnett P. McMillan, N. Martchenke, et al.
Journal of Cancer Survivorship (2023) Vol. 17, Iss. 1, pp. 82-100
Closed Access | Times Cited: 5
Direct Targeting of Mitochondria by Cisplatin Leads to Cytotoxicity in Zebrafish Lateral Line Hair Cells
David S. Lee, Angela Schrader, Jiaoxia Zou, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 110975-110975
Open Access | Times Cited: 1
The Effects of Substance Misuse on Auditory and Vestibular Function: A Systematic Review
Amanda Chiao, Michelle L. Hughes, Priya Karimuddanahalli Premkumar, et al.
Ear and Hearing (2023) Vol. 45, Iss. 2, pp. 276-296
Closed Access | Times Cited: 3
Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors
Christine Miaskowski, Judy Mastick, Steven M. Paul, et al.
Journal of Cancer Survivorship (2022) Vol. 17, Iss. 1, pp. 59-68
Open Access | Times Cited: 5
Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer
Mohammad Shahbazi, Xindi Zhang, Paul C. Dinh, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 2999-3012
Open Access | Times Cited: 4
Cisplatin drives mitochondrial dysregulation in sensory hair cells
David S. Lee, Angela Schrader, Jiaoxia Zou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Trends in ototoxicity monitoring among cisplatin-treated patients with cancer
David S. Lee, Emma Y. Travis, Susan K. Wong, et al.
Journal of Cancer Survivorship (2024)
Closed Access
Histamine deficiency exacerbates cisplatin-induced ferroptosis in cochlea hair cells of HDC knockout mice
Daquan Wu, Baoling Zhu, Xiyang Yang, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112639-112639
Closed Access
Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment
Katharine Fernandez, Alex E. Hoetink, Dawn Konrad‐Martin, et al.
Ear and Hearing (2024)
Closed Access
Prevention and treatment of platinum ototoxicity in adults: A systematic review
Juan Esteban Correa‐Morales, Sara Giraldo‐Moreno, Nidia Mantilla‐Manosalva, et al.
Authorea (Authorea) (2023)
Open Access
Chemotherapy-Induced Cranial Nerve Damage
Susanna B. Park, Matthew C. Kiernan
Springer eBooks (2023), pp. 189-193
Closed Access
Prevalence and Risk Factors for Ototoxicity After Cisplatin-based Chemotherapy
Victoria A. Sanchez, Paul C. Dinh, Jennessa Rooker, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top